N6 -methyladenosine-induced ERRγ triggers chemoresistance of cancer cells through upregulation of ABCB1 and metabolic reprogramming: Erratum

Zhuojia Chen,Long Wu,Jiawang Zhou,Xinyao Lin,Yanxi Peng,Lichen Ge,Cheng-Ming Chiang,Hui Huang,Hongsheng Wang,Weiling He

DOI: https://doi.org/10.7150/thno.85930

IF: 11.6

2023-01-01

Theranostics

Abstract:[This corrects the article DOI: 10.7150/thno.40144.].

medicine, research & experimental

What problem does this paper attempt to address?

Erratum: Targeting NF-κB/AP-2β Signaling to Enhance Antitumor Activity of Cisplatin by Melatonin in Hepatocellular Carcinoma Cells.

Jiaojiao Hao,Zhenglin Li,Changlin Zhang,Wendan Yu,Zhipeng Tang,Yixin Li,Xu Feng,Yue Gao,Quentin Liu,Wenlin Huang,Wei Guo,Wuguo Deng

DOI: https://doi.org/10.62347/suki5933

2024-01-01

American journal of cancer research

Abstract:[This corrects the article on p. 13 in vol. 7, PMID: 28123844.].
Corrigendum: RNA m6A methylation regulates the ultraviolet-induced DNA damage response.

Yang Xiang,Benoit Laurent,Chih-Hung Hsu,Sigrid Nachtergaele,Zhike Lu,Wanqiang Sheng,Chuanyun Xu,Hao Chen,Jian Ouyang,Siqing Wang,Dominic Ling,Pang-Hung Hsu,Lee Zou,Ashwini Jambhekar,Chuan He,Yang Shi

DOI: https://doi.org/10.1038/nature24007

IF: 64.8

2017-01-01

Nature

Abstract:This corrects the article DOI: 10.1038/nature21671.
Aldehyde dehydrogenase 1A1 confers erlotinib resistance via facilitating the reactive oxygen species-reactive carbonyl species metabolic pathway in lung adenocarcinomas: Erratum

Hui-Min Lei,Ke-Ren Zhang,Cong Hui Wang,Yang Wang,Guang-Lei Zhuang,Li-Ming Lu,Jian Zhang,Ying Shen,Hong-Zhuan Chen,Liang Zhu

DOI: https://doi.org/10.7150/thno.84874

IF: 11.6

2023-01-01

Theranostics

Abstract:[This corrects the article DOI: 10.7150/thno.35729.].

medicine, research & experimental
Overcoming erlotinib resistance in EGFR mutation-positive lung adenocarcinomas through repression of phosphoglycerate dehydrogenase: Erratum

Jiang-Kai Dong,Hui-Min Lei,Qian Liang,Ya-Bin Tang,Ye Zhou,Yang Wang,Shengzhe Zhang,Wen-Bin Li,Yunguang Tong,Guanglei Zhuang,Liang Zhang,Hong-Zhuan Chen,Liang Zhu,Ying Shen

DOI: https://doi.org/10.7150/thno.58558

IF: 11.6

2021-01-01

Theranostics

Abstract:[This corrects the article DOI: 10.7150/thno.23177.].

medicine, research & experimental
Erratum: Adipocytes fuel gastric cancer omental metastasis via PITPNC1-mediated fatty acid metabolic reprogramming: Erratum

Yujing Tan,Kelin Lin,Yang Zhao,Qijing Wu,Dongping Chen,Jin Wang,Yanxiao Liang,Jingyu Li,Jiazhu Hu,Hao Wang,Yajing Liu,Shuyi Zhang,Wanming He,Qiong Huang,Xingbin Hu,Zhiqi Yao,Bishan Liang,Wangjun Liao,Min Shi

DOI: https://doi.org/10.7150/thno.101689

IF: 11.6

2024-09-05

Theranostics

Abstract:[This corrects the article DOI: 10.7150/thno.28219.].
Erratum: Exogenous glutathione contributes to cisplatin resistance in lung cancer A549 cells.

Dong Lan,Li Wang,Rongquan He,Jie Ma,Yehong Bin,Xiaojv Chi,Gang Chen,Zhengwen Cai

2018-01-01

American journal of translational research

Abstract:[This corrects the article on p. 1295 in vol. 10, PMID: 29887946.].
Involvement of miR-619-5p in resistance to cisplatin by regulating ATXN3 in oral squamous cell carcinoma: Erratum

An Song,Yuanyuan Wu,Weiming Chu,Xueming Yang,Zaiou Zhu,Enshi Yan,Wei Zhang,Junbo Zhou,Xu Ding,Jie Liu,Hongxia Zhu,Jinhai Ye,Yunong Wu,Yang Zheng,Xiaomeng Song

DOI: https://doi.org/10.7150/ijbs.94832

2024-01-01

International Journal of Biological Sciences

Abstract:[This corrects the article DOI: 10.7150/ijbs.54014.].

biochemistry & molecular biology
Correction To: Therapeutic Efficacy, Pharmacokinetic Profiles, and Toxicological Activities of Humanized Antibody-Drug Conjugate Zt/g4-MMAE Targeting RON Receptor Tyrosine Kinase for Cancer Therapy

Hang-Ping Yao,Liang Feng,Sreedhar Reddy Suthe,Ling-Hui Chen,Tian-Hao Weng,Chen-Yu Hu,Eun Sung Jun,Zhi-Gang Wu,Wei-Lin Wang,Song Cheol Kim,Xiang-Min Tong,Ming-Hai Wang

DOI: https://doi.org/10.1186/s40425-019-0571-7

IF: 12.469

2019-01-01

Journal for ImmunoTherapy of Cancer

Abstract:Following publication of the original article [1], the author reported two errors in the authors affiliations:
Corrigendum to "N6-methyladenosine modified LINC00901 promotes pancreatic cancer progression through IGF2BP2/MYC axis" [Genes & Diseases 10 (2023) 554-567]

Wan-Xin Peng,Fei Liu,Jia-Hong Jiang,Hang Yuan,Ziqiang Zhang,Liu Yang,Yin-Yuan Mo

DOI: https://doi.org/10.1016/j.gendis.2024.101352

2024-06-15

Abstract:[This corrects the article DOI: 10.1016/j.gendis.2022.02.014.].
Correction to: Human drug efflux transporter ABCC5 confers acquired resistance to pemetrexed in breast cancer

Jihui Chen,Zhipeng Wang,Shouhong Gao,Kejin Wu,Fang Bai,Qiqiang Zhang,Hongyu Wang,Qin Ye,Fengjing Xu,Hong Sun,Yunshu Lu,Yan Liu

DOI: https://doi.org/10.1186/s12935-021-01876-1

IF: 6.429

2021-03-25

Cancer Cell International

Abstract:An amendment to this paper has been published and can be accessed via the original article.

oncology
Thioredoxin 1 supports colorectal cancer cell survival and promotes migration and invasion under glucose deprivation through interaction with G6PD: Erratum

Fengying Lu,Daoquan Fang,Shuhan Li,Zuyue Zhong,Xiujiao Jiang,Qinqin Qi,Yining Liu,Wenqi Zhang,Xiaohui Xu,Yangyang Liu,Weijian Zhu,Lei Jiang

DOI: https://doi.org/10.7150/ijbs.94220

2024-01-01

International Journal of Biological Sciences

Abstract:[This corrects the article DOI: 10.7150/ijbs.71809.].

biochemistry & molecular biology
Erratum: CD151 promotes Colorectal Cancer progression by a crosstalk involving CEACAM6, LGR5 and Wnt signaling via TGFβ1: Erratum.

Tao Yang,Huibing Wang,Meng Li,Linqi Yang,Yu Han,Chao Liu,Baowen Zhang,Mingfa Wu,Gang Wang,Zhenya Zhang,Wenqi Zhang,Jianming Huang,Huaxing Zhang,Ting Cao,Pingping Chen,Wei Zhang

DOI: https://doi.org/10.7150/ijbs.84867

2023-01-01

International Journal of Biological Sciences

Abstract:[This corrects the article DOI: 10.7150/ijbs.53657.].
Myeloid cell-derived LL-37 promotes lung cancer growth by activating Wnt/β-catenin signaling: Erratum

Ping Ji,Yongxin Zhou,Yibao Yang,Junlu Wu,Hao Zhou,Wenqiang Quan,Junjun Sun,Yiwen Yao,Anquan Shang,Chenzheng Gu,Bingjie Zeng,Jenni Firrman,Weidong Xiao,Robert Bals,Zujun Sun,Dong Li

DOI: https://doi.org/10.7150/thno.82877

IF: 11.6

2023-01-01

Theranostics

Abstract:[This corrects the article DOI: 10.7150/thno.30726.].

medicine, research & experimental
Erratum: Dual inhibition of PFKFB3 and VEGF normalizes tumor vasculature, reduces lactate production, and improves chemotherapy in glioblastoma: insights from protein expression profiling and MRI: Erratum

Junfeng Zhang,Wei Xue,Kai Xu,Liang Yi,Yu Guo,Tian Xie,Haipeng Tong,Bo Zhou,Shunan Wang,Qing Li,Heng Liu,Xiao Chen,Jingqin Fang,Weiguo Zhang

DOI: https://doi.org/10.7150/thno.92042

IF: 11.6

2023-11-17

Theranostics

Abstract:[This corrects the article DOI: 10.7150/thno.44427.].
Inhibition of SMYD2 suppresses tumor progression by down-regulating microRNA-125b and attenuates multi-drug resistance in renal cell carcinoma: Erratum

Libin Yan,Beichen Ding,Haoran Liu,Yangjun Zhang,Jin Zeng,Junhui Hu,Weimin Yao,Gan Yu,Ruihua An,Zhiqiang Chen,Zhangqun Ye,Jinchun Xing,Kefeng Xiao,Lily Wu,Hua Xu

DOI: https://doi.org/10.7150/thno.68810

IF: 11.6

2022-01-01

Theranostics

Abstract:[This corrects the article DOI: 10.7150/thno.37628.].

medicine, research & experimental
Corrigendum: Regulation of microrna-497-targeting AKT2 influences tumor growth and chemoresistance to cisplatin in lung cancer

Lin Wang,Xiang-Bo Ji,Li-Hong Wang,Jian-Ge Qiu,Feng-Mei Zhou,Wen-Jing Liu,Di-di Wan,Marie Chai-mi Lin,Ling-Zhi Liu,Jian-Ying Zhang,Bing-Hua Jiang

DOI: https://doi.org/10.3389/fcell.2022.1008088

IF: 5.5

2022-09-23

Frontiers in Cell and Developmental Biology

Abstract:[This corrects the article DOI: 10.3389/fcell.2020.00840.].

cell biology,developmental biology
Corrigendum to “Suppression of IL-6 Gene by shRNA Augments Gemcitabine Chemosensitization in Pancreatic Adenocarcinoma Cells”

Haibo Xing,Mengting Tong,Jing Wang,Hanqing Hu,Chongya Zhai,Chunhui Huang,Da Li

DOI: https://doi.org/10.1155/2022/9767389

2022-01-01

BioMed Research International

Abstract:[This corrects the article DOI: 10.1155/2018/3195025.].
Corrigendum to "A Novel Inhibitor of MDM2 Oncogene Blocks Metastasis of Hepatocellular Carcinoma and Overcomes Chemoresistance" [genes Dis 694 (2019) 419-430].

Wei Wang,Bo Hu,Jiang-Jiang Qin,Jianwen Cheng,Xin Li,Mehrdad Rajaei,Jia Fan,Xin-Rong Yang,Ruiwen Zhang

DOI: https://doi.org/10.1016/j.gendis.2019.12.006

IF: 7.376

2019-01-01

Genes & Diseases

Abstract:[This corrects the article DOI: 10.1016/j.gendis.2019.06.001.].
Targeting Epstein-Barr virus oncoprotein LMP1-mediated high oxidative stress suppresses EBV lytic reactivation and sensitizes tumors to radiation therapy: Erratum

Jianmin Hu,Yueshuo Li,Hongde Li,Feng Shi,Longlong Xie,Lin Zhao,Min Tang,Xiangjian Luo,Weihua Jia,Jia Fan,Jian Zhou,Qiang Gao,Shuangjian Qiu,Weizhong Wu,Xin Zhang,Weihua Liao,Ann M. Bode,Ya Cao

DOI: https://doi.org/10.7150/thno.73630

IF: 11.6

2022-01-01

Theranostics

Abstract:[This corrects the article DOI: 10.7150/thno.46006.].

medicine, research & experimental
Publisher Correction: N6-Methyladenosine Methyltransferase ZCCHC4 Mediates Ribosomal RNA Methylation

Honghui Ma,Xiaoyun Wang,Jia‐Bin Cai,Qing Dai,S. Kundhavai Natchiar,Ruitu Lv,Kai Chen,Zhike Lu,Hao Chen,Yujiang Geno Shi,Fei Lan,Jian‐Gao Fan,Bruno P. Klaholz,Tao Pan,Yang Shi,Chuan He

DOI: https://doi.org/10.1038/s41589-019-0233-6

IF: 14.8

2019-01-01

Nature Chemical Biology

Abstract:In the version of this article originally published, the references were incorrectly re-ordered during production. The hyphen in “N6-methyladenosine” in the title was also superscript. The errors have been corrected in the HTML and PDF versions of the paper.

N6 -methyladenosine-induced ERRγ triggers chemoresistance of cancer cells through upregulation of ABCB1 and metabolic reprogramming: Erratum

Erratum: Targeting NF-κB/AP-2β Signaling to Enhance Antitumor Activity of Cisplatin by Melatonin in Hepatocellular Carcinoma Cells.

Corrigendum: RNA m6A methylation regulates the ultraviolet-induced DNA damage response.

Aldehyde dehydrogenase 1A1 confers erlotinib resistance via facilitating the reactive oxygen species-reactive carbonyl species metabolic pathway in lung adenocarcinomas: Erratum

Overcoming erlotinib resistance in EGFR mutation-positive lung adenocarcinomas through repression of phosphoglycerate dehydrogenase: Erratum

Erratum: Adipocytes fuel gastric cancer omental metastasis via PITPNC1-mediated fatty acid metabolic reprogramming: Erratum

Erratum: Exogenous glutathione contributes to cisplatin resistance in lung cancer A549 cells.

Involvement of miR-619-5p in resistance to cisplatin by regulating ATXN3 in oral squamous cell carcinoma: Erratum

Correction To: Therapeutic Efficacy, Pharmacokinetic Profiles, and Toxicological Activities of Humanized Antibody-Drug Conjugate Zt/g4-MMAE Targeting RON Receptor Tyrosine Kinase for Cancer Therapy

Corrigendum to "N6-methyladenosine modified LINC00901 promotes pancreatic cancer progression through IGF2BP2/MYC axis" [Genes & Diseases 10 (2023) 554-567]

Correction to: Human drug efflux transporter ABCC5 confers acquired resistance to pemetrexed in breast cancer

Thioredoxin 1 supports colorectal cancer cell survival and promotes migration and invasion under glucose deprivation through interaction with G6PD: Erratum

Erratum: CD151 promotes Colorectal Cancer progression by a crosstalk involving CEACAM6, LGR5 and Wnt signaling via TGFβ1: Erratum.

Myeloid cell-derived LL-37 promotes lung cancer growth by activating Wnt/β-catenin signaling: Erratum

Erratum: Dual inhibition of PFKFB3 and VEGF normalizes tumor vasculature, reduces lactate production, and improves chemotherapy in glioblastoma: insights from protein expression profiling and MRI: Erratum

Inhibition of SMYD2 suppresses tumor progression by down-regulating microRNA-125b and attenuates multi-drug resistance in renal cell carcinoma: Erratum

Corrigendum: Regulation of microrna-497-targeting AKT2 influences tumor growth and chemoresistance to cisplatin in lung cancer

Corrigendum to “Suppression of IL-6 Gene by shRNA Augments Gemcitabine Chemosensitization in Pancreatic Adenocarcinoma Cells”

Corrigendum to "A Novel Inhibitor of MDM2 Oncogene Blocks Metastasis of Hepatocellular Carcinoma and Overcomes Chemoresistance" [genes Dis 694 (2019) 419-430].

Targeting Epstein-Barr virus oncoprotein LMP1-mediated high oxidative stress suppresses EBV lytic reactivation and sensitizes tumors to radiation therapy: Erratum

Publisher Correction: N6-Methyladenosine Methyltransferase ZCCHC4 Mediates Ribosomal RNA Methylation